Injective Eyes Massive Breakout Potential as Technicals and On-chain Growth Align

Injective (INJ) is poised for a breakout after completing a significant 87% correction, now trading below $17. This marks a crucial moment in its journey, with accumulation between $6.50 and $10 signaling strong investor confidence ahead of an anticipated surge. The ecosystem’s growth and technical positioning are perfectly aligned, suggesting INJ could surge towards the $50, $100, and beyond levels.